Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway

European Journal of Pharmacology

Volumn 770, Issue , 2016, Pages 1-8

  Xu, Xin Rong ^a   Yu, Hai Tao ^a   Yang, Yan ^a   Hang, Li ^a   Yang, Xue Wen ^a   Ding, Shu Hua ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Age related macular degeneration; Nrf2; Oxidative stress; Phospholipid complex; Quercetin

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; MALONALDEHYDE; OXIDOREDUCTASE; QUERCETIN; QUERCETIN PHOSPHOLIPID COMPLEX; QUINONE OXIDOREDUCTASE 1; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; HYDROGEN PEROXIDE; PHOSPHOLIPID;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MECHANISM; DRUG SOLUBILITY; DRUG STRUCTURE; ENZYME ACTIVITY; GENE EXPRESSION; GLUTAMATE CYSTEINE LIGASE GENE; HO 1 GENE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; NQO 1 GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; X RAY DIFFRACTION; CELL DEATH; CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM;

ANTIOXIDANTS; CELL DEATH; CELL LINE; CYTOPROTECTION; HUMANS; HYDROGEN PEROXIDE; METABOLIC DETOXICATION, PHASE II; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHOSPHOLIPIDS; QUERCETIN; SIGNAL TRANSDUCTION;

EID: 84948735698     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.11.050     Document Type: Article

References (21)

1. M. Alia, S. Ramos, R. Mateos, A.B. Granado-Serrano, L. Bravo, and L. Goya Quercetin protects human hepatoma HepG2 against oxidative stress induced by tert-butyl hydroperoxide Toxicol. Appl. Pharmacol. 212 2006 110 118
2. E. Buschini, A.M. Fea, C.A. Lavia, M. Nassisi, G. Pignata, M. Zola, and F.M. Grignolo Recent developments in the management of dry age-related macular degeneration Clin. Ophthalmol. 9 2015 563 574
3. X. Cai, Z. Fang, J. Dou, A. Yu, and G. Zhai Bioavailability of quercetin: problems and promises Curr. Med. Chem. 20 2013 2572 2582
4. J. Choi, T. Konno, M. Takai, and K. Ishihara Controlled drug release from multilayered phospholipid polymer hydrogel on titanium alloy surface Biomaterials 30 2009 5201 5208
5. A. Hanneken, F.F. Lin, J. Johnson, and P. Maher Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death Invest. Ophthalmol. Vis. Sci. 47 2006 3164 3177
6. L.J. Hernandez-Pastor, A. Ortega, A. Garcia-Layana, and J. Giraldez Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration Graefes Arch. Clin. Exp. Ophthalmol. 248 2010 467 476
7. M. Ishikawa, D. Jin, Y. Sawada, S. Abe, and T. Yoshitomi Future therapies of wet age-related macular degeneration J. Ophthalmol. 2015 2015 138070
8. K. Ishizawa, M. Yoshizumi, Y. Kawai, J. Terao, Y. Kihira, Y. Ikeda, S. Tomita, K. Minakuchi, K. Tsuchiya, and T. Tamaki Pharmacology in health food: metabolism of quercetin in vivo and its protective effect against arteriosclerosis J. Pharmacol. Sci. 115 2011 466 470
9. K. Itoh, J. Mimura, and M. Yamamoto Discovery of the negative regulator of Nrf2, Keap1: a historical overview Antioxid. Redox Signal. 13 2010 1665 1678
10. R. Klein, and B.E. Klein The prevalence of age-related eye diseases and visual impairment in aging: current estimates Invest. Ophthalmol. Vis. Sci. 54 2013 pp. ORSF5-ORSF13
11. X. Li, G. Xu, Y. Wang, X. Xu, X. Liu, S. Tang, F. Zhang, J. Zhang, L. Tang, Q. Wu, D. Luo, and X. Ke Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study Ophthalmology 121 2014 1740 1747
12. Z. Li, X. Dong, H. Liu, X. Chen, H. Shi, Y. Fan, D. Hou, and X. Zhang Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt Mol. Vis. 19 2013 1656 1666
13. Q. Ma Role of nrf2 in oxidative stress and toxicity Annu. Rev. Pharmacol. Toxicol. 53 2013 401 426
14. P.S. Mettu, A.R. Wielgus, S.S. Ong, and S.W. Cousins Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration Mol. Asp. Med. 33 2012 376 398
15. G. Querques, P.J. Rosenfeld, E. Cavallero, E. Borrelli, F. Corvi, L. Querques, F.M. Bandello, and M.A. Zarbin Treatment of dry age-related macular degeneration Ophthalmic. Res. 52 2014 107 115
16. T. Rezaie, S.R. McKercher, K. Kosaka, M. Seki, L. Wheeler, V. Viswanath, T. Chun, R. Joshi, M. Valencia, S. Sasaki, T. Tozawa, T. Satoh, and S.A. Lipton Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration Invest. Ophthalmol. Vis. Sci. 53 2012 7847 7854
17. T.D. Schmittgen, B.A. Zakrajsek, A.G. Mills, V. Gorn, M.J. Singer, and M.W. Reed Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and real-time methods Anal. Biochem. 285 2000 194 204
18. D. Singh, M.S. Rawat, A. Semalty, and M. Semalty Quercetin-phospholipid complex: an amorphous pharmaceutical system in herbal drug delivery Curr. Drug. Discov. Technol. 9 2012 17 24
19. X. Xu, L. Hang, B. Huang, Y. Wei, S. Zheng, and W. Li Efficacy of ethanol extract of fructus lycii and its constituents lutein/zeaxanthin in protecting retinal pigment epithelium cells against oxidative stress: in vivo and in vitro models of age-related macular degeneration J. Ophthalmol. 2013 2013 862806
20. D.D. Zhang Mechanistic studies of the Nrf2-Keap1 signaling pathway Drug. Metab. Rev. 38 2006 769 789
21. Z. Zhao, Y. Chen, J. Wang, P. Sternberg, M.L. Freeman, H.E. Grossniklaus, and J. Cai Age-related retinopathy in NRF2-deficient mice PLoS One 6 2011 e19456